Zhang Cuilin, Olsen Sjurdur F, Hinkle Stefanie N, Gore-Langton Robert E, Vaag Allan, Grunnet Louise Groth, Yeung Edwina H, Bao Wei, Bowers Katherine, Liu Aiyi, Mills James L, Sherman Seth, Gaskins Audrey J, Ley Sylvia H, Madsen Camilla M, Chavarro Jorge E, Hu Frank B
Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
BMJ Open. 2019 May 1;9(4):e025517. doi: 10.1136/bmjopen-2018-025517.
Women who experience gestational diabetes mellitus (GDM) are at exceptionally high-risk of developing type 2 diabetes (T2DM) later in life. However, limited information is available about genetic and environmental factors that are implicated in the progression from GDM to T2DM.
The Diabetes & Women's Health (DWH) Study applied a hybrid design, which combined new prospective data collection with existing data in two prospective cohorts, the Danish National Birth Cohort (DNBC) and the Nurses' Health Study II (NHS II). In total, the DWH Study identified 7759 women with a GDM diagnosis from both cohorts; 4457 women participated in the DWH Study data collection, which included two cycles of follow-up from 2012 to 2014 and 2014 to 2016.
Progression from GDM to T2DM was high. In the NHS II group, by 2013, 23.1% (n=846/3667) developed T2DM. In the DNBC group, at cycle 1 (2012-2014), the progression rate was even higher: 27.2% (n=215/790) had developed T2DM. Furthermore, we have shown that women who had GDM experienced a significantly greater risk of hypertension and cardiovascular diseases, as well as early stages of glomerular hyperfiltration and renal damage. Moreover, the DWH Study findings have shown that healthful diet and lifestyle factors and weight control were related to a lower risk of T2DM, hypertension and cardiovascular diseases.
Primary data collection for the DWH Study is complete and investigators are currently investigating interactions of the abovementioned modifiable factors with T2DM genetic susceptibility in determining the risk of progression from GDM to T2DM. Findings from ongoing work will provide further insights for identifying more precise prevention strategies for T2DM and comorbidities in this high-risk population. Future work will examine novel biomarkers of health and disease in this cohort.
患有妊娠期糖尿病(GDM)的女性在其生命后期患2型糖尿病(T2DM)的风险极高。然而,关于从GDM进展到T2DM的遗传和环境因素的信息有限。
糖尿病与女性健康(DWH)研究采用了混合设计,将新的前瞻性数据收集与丹麦国家出生队列(DNBC)和护士健康研究II(NHS II)这两个前瞻性队列中的现有数据相结合。DWH研究总共从两个队列中识别出7759名被诊断为GDM的女性;4457名女性参与了DWH研究的数据收集,其中包括2012年至2014年以及2014年至2016年的两个随访周期。
从GDM进展到T2DM的比例很高。在NHS II组中,到2013年,23.1%(n = 846/3667)的女性患了T2DM。在DNBC组中,在第1周期(2012 - 2014年),进展率更高:27.2%(n =